130 related articles for article (PubMed ID: 29135538)
1. Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.
Baldauf JJ; Fender M; Bergeron C; Marrer E; Velten M; Pradat P; Arbyn M
Eur J Cancer Prev; 2019 Jan; 28(1):33-39. PubMed ID: 29135538
[TBL] [Abstract][Full Text] [Related]
2. [EVE, a regional campaign for the screening of cervical cancer. Organization, 7-years results and perspectives].
Fender M; Schott J; Baldauf JJ; Muller J; Schlund E; Dellenbach P;
Presse Med; 2003 Oct; 32(33):1545-51. PubMed ID: 14576592
[TBL] [Abstract][Full Text] [Related]
3. Population-based organized cervical cancer screening pilot program in France.
Hamers FF; Duport N; Beltzer N
Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer screening, human papillomavirus vaccination practices and current infrastructure in Israel.
Schejter E; Bornstein J; Siegler E
Vaccine; 2013 Nov; 31 Suppl 8():I42-5. PubMed ID: 24229718
[TBL] [Abstract][Full Text] [Related]
5. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study.
Maura G; Chaignot C; Weill A; Alla F; Heard I
Eur J Cancer Prev; 2018 Sep; 27(5):479-485. PubMed ID: 28368950
[TBL] [Abstract][Full Text] [Related]
7. [Can we and must we organize cervical cancer screening in France? Results of the pilot project "EVE" in the department of Bas-Rhin].
Fender M; Schaffer P; Dellenbach P
J Gynecol Obstet Biol Reprod (Paris); 1998 Nov; 27(7):683-91. PubMed ID: 9921438
[TBL] [Abstract][Full Text] [Related]
8. [Implementation of National Cervical Cancer Screening Program in France].
Woronoff AS; Molinié F; Trétarre B
Bull Cancer; 2019 Mar; 106(3):253-261. PubMed ID: 30635113
[TBL] [Abstract][Full Text] [Related]
9. Excess cervical cancer screening smears: Any benefit? A retrospective cohort in Alsace, France.
Thiery A; Akladios C; Fender M; Severac F; Baldauf JJ
J Med Screen; 2017 Jun; 24(2):92-97. PubMed ID: 27206814
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer incidence in British Columbia: Predicting effects of changes from Pap to human papillomavirus screening and of changes in screening participation.
Coldman A; van Niekerk D; Smith L; Ogilvie G
J Med Screen; 2017 Dec; 24(4):195-200. PubMed ID: 27810984
[TBL] [Abstract][Full Text] [Related]
11. Performance indicators in a newly established organized cervical screening programme: registry-based analysis in the Czech Republic.
Májek O; Dušková J; Dvořák V; Beková A; Klimeš D; Blaha M; Anttila A; Dušek L
Eur J Cancer Prev; 2017 May; 26(3):232-239. PubMed ID: 26908155
[TBL] [Abstract][Full Text] [Related]
12. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
14. [Organized cervical cancer screening for underpriviledged women].
Piana L; Leandri FX; Jacqueme B; Heid P; Corti J; Andrac-Meyer L; Sancho-Garnier H
Bull Cancer; 2007 May; 94(5):461-7. PubMed ID: 17535784
[TBL] [Abstract][Full Text] [Related]
15. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
[TBL] [Abstract][Full Text] [Related]
16. Success of a cervical cancer screening program: trends in incidence in songkhla, southern Thailand, 1989-2010, and prediction of future incidences to 2030.
Sriplung H; Singkham P; Iamsirithaworn S; Jiraphongsa C; Bilheem S
Asian Pac J Cancer Prev; 2014; 15(22):10003-8. PubMed ID: 25520060
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer screening in France.
Schaffer P; Sancho-Garnier H; Fender M; Dellenbach P; Carbillet JP; Monnet E; Gauthier GP; Garnier A
Eur J Cancer; 2000 Nov; 36(17):2215-20. PubMed ID: 11072207
[TBL] [Abstract][Full Text] [Related]
18. Screening for cervical cancer in French Guiana: screening rates from 2006 to 2011.
Douine M; Roué T; Lelarge C; Adenis A; Thomas N; Nacher M
Bull Soc Pathol Exot; 2015 Dec; 108(5):355-9. PubMed ID: 26608273
[TBL] [Abstract][Full Text] [Related]
19. Sociodemographic inequalities in sexual activity and cervical cancer screening: implications for the success of human papillomavirus vaccination.
Drolet M; Boily MC; Greenaway C; Deeks SL; Blanchette C; Laprise JF; Brisson M
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):641-52. PubMed ID: 23549400
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the National Cervical Cancer Screening Programme in Singapore.
Jin AZ; Louange EC; Chow KY; Fock CW
Singapore Med J; 2013 Feb; 54(2):96-101. PubMed ID: 23462834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]